120 related articles for article (PubMed ID: 9042293)
1. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity.
Koita H; Suzumiya J; Ohshima K; Takeshita M; Kimura N; Kikuchi M; Koono M
Am J Surg Pathol; 1997 Feb; 21(2):242-8. PubMed ID: 9042293
[TBL] [Abstract][Full Text] [Related]
2. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
3. Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression.
Isobe K; Tamaru JI; Nakamura S; Itami J; Aruga T; Uno T; Yasuda S; Mikata A; Ito H
Pathol Int; 2001 Jan; 51(1):55-9. PubMed ID: 11148466
[TBL] [Abstract][Full Text] [Related]
4. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
5. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
6. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
7. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
8. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
10. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms.
Liu Q; Ohshima K; Sumie A; Suzushima H; Iwasaki H; Kikuchi M
Virchows Arch; 2001 Mar; 438(3):271-9. PubMed ID: 11315624
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
12. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
[TBL] [Abstract][Full Text] [Related]
13. Aggressive natural killer cell lymphoma presenting as an anterior mediastinal mass in a patient with acquired immunodeficiency syndrome.
Tao J; Savargaonkar P; Vallejo C; Cesarman E; Fuchs A
Arch Pathol Lab Med; 2000 Feb; 124(2):304-9. PubMed ID: 10656746
[TBL] [Abstract][Full Text] [Related]
14. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas.
Kojima H; Mukai HY; Shinagawa A; Yoshida C; Kamoshita M; Komeno T; Hasegawa Y; Yamashita Y; Mori N; Nagasawa T
Int J Hematol; 2000 Dec; 72(4):477-83. PubMed ID: 11197216
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.
Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K
Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131
[TBL] [Abstract][Full Text] [Related]
17. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
18. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
19. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
20. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
